FSCN2
Fascin-2
Also known as: FSCN2_HUMAN, RFSN, RP30
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14926
- Gene
- FSCN2
- Ensembl
- ENSG00000186765
- Chromosome
- 17
- Canonical length
- 492 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the fascin protein family. Fascins crosslink actin into filamentous bundles within dynamic cell extensions. This family member is proposed to play a role in photoreceptor disk morphogenesis. A mutation in this gene results in one form of autosomal dominant retinitis pigmentosa and macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
492 residues, UniProt reviewed canonical sequence.
>O14926|FSCN2
1 MPTNGLHQVL KIQFGLVNDT DRYLTAESFG FKVNASAPSL KRKQTWVLEP DPGQGTAVLL
61 RSSHLGRYLS AEEDGRVACE AEQPGRDCRF LVLPQPDGRW VLRSEPHGRF FGGTEDQLSC
121 FATAVSPAEL WTVHLAIHPQ AHLLSVSRRR YVHLCPREDE MAADGDKPWG VDALLTLIFR
181 SRRYCLKSCD SRYLRSDGRL VWEPEPRACY TLEFKAGKLA FKDCDGHYLA PVGPAGTLKA
241 GRNTRPGKDE LFDLEESHPQ VVLVAANHRY VSVRQGVNVS ANQDDELDHE TFLMQIDQET
301 KKCTFYSSTG GYWTLVTHGG IHATATQVSA NTMFEMEWRG RRVALKASNG RYVCMKKNGQ
361 LAAISDFVGK DEEFTLKLIN RPILVLRGLD GFVCHHRGSN QLDTNRSVYD VFHLSFSDGA
421 YRIRGRDGGF WYTGSHGSVC SDGERAEDFV FEFRERGRLA IRARSGKYLR GGASGLLRAD
481 ADAPAGTALW EYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FSCN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 8.1 nTPM
Expression across tissuesHPA
Tissue
- retina: 8.1 nTPM
- pancreas: 4.4 nTPM
- thyroid gland: 3.9 nTPM
- parathyroid gland: 1.9 nTPM
- salivary gland: 1.7 nTPM
- kidney: 1.2 nTPM
Single-cell type
- pancreatic acinar cells: 30 nCPM
- rod photoreceptor cells: 21 nCPM
- cone photoreceptor cells: 19 nCPM
- epicardial cells: 6.8 nCPM
- late spermatids: 4.3 nCPM
- medullary thymic epithelial cells: 2.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 4.1 nTPM
- medulla oblongata: 3.4 nTPM
- spinal cord: 2.8 nTPM
- cerebral cortex: 2.7 nTPM
- white matter: 2.7 nTPM
- basal ganglia: 2.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FSCN2.
Disease | AllUniProt
Conditions FSCN2 is implicated in, by any mechanism.
- Retinitis pigmentosa 30 (RP30) MIM:607921
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 735 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.11
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- actin filament bundle assembly
- anatomical structure morphogenesis
- cell migration
- establishment or maintenance of cell polarity
- eye photoreceptor cell development
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FSCN2 as an antibody target. Whether an autoantibody or antibody against FSCN2 could matter depends on whether native FSCN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FSCN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FSCN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...